Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 8Recruiting 4Active not recruiting 3Unknown 2Terminated 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 26Pancreatic Neoplasms 12Stomach Neoplasms 11Colonic Neoplasms 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Esophageal Neoplasms 7Adenocarcinoma Of Esophagus 7Burkitt Lymphoma 6Neoplasms 5Cholangiocarcinoma 5Neoplasm Metastasis 4Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Leukemia, Biphenotypic, Acute 2Leukemia 2Gallbladder Neoplasms 2Carcinoma, Renal Cell 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Urachal cancer 1Unresectable Colorectal Cancer 1

Interventions

Leucovorin 3Fluorouracil 3irinotecan sucrosofate 2Surveys and Questionnaires 2Standard of Care 2Radiosurgery 2Practice Guidelines as Topic 2Oxaliplatin 2Nivolumab 2tislelizumab 1rucaparib 1folfirinox 1fludarabine 1encorafenib 1durvalumab 1dehydroftorafur 1canakinumab 1avatrombopag 1aldesleukin 1Transurethral Resection of Prostate 1Sodium Chloride 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Psilocybin 1Poly(ADP-ribose) Polymerase Inhibitors 1Panitumumab 1Observation 1Massage 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Neoplasms × Leucovorin × Clear all
NCT04005339 2026-01-26

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Georgetown University

Phase 2 Active not recruiting
48 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT03337087 2024-05-17

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Academic and Community Cancer Research United

Phase 1/2 Active not recruiting
18 enrolled 12 charts
Gastrointestinal

Gastrointestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡